Press
Latest News & Insights
카리스바이오, 셀리노와 MTA 체결.. iPSC 치료제 생산 자동화 나서
Cellino Announces Partnership with Karis Bio to Develop First Nebula™-Powered Autologous iPSC Therapy for Cardiovascular Disease
Cellino Announces Partnership with Karis Bio to Develop First Nebula™-Powered Autologous iPSC Therapy for Cardiovascular Disease
Cellino, Karis Bio Partner on Autologous iPSC-Based Therapy for Cardiovascular Disease
Cellino Announces Partnership with Karis Bio to Develop First Nebula™-Powered Autologous iPSC Therapy for Cardiovascular Disease
Cellino, Matricelf Team Up to Scale Personalized Spinal Cord Injury Treatments
Cellino’s Regenerative Medicine Tie-Up with Matricelf Is a Step Forward for Longevity
The Future of Spinal Cord Injury Treatment: How Cellino and Matricelf Are Leading the Way
Cellino and Matricelf Announce Global Collaboration to Scale Personalized Spinal Cord Injury Treatments